Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Enterprise Value: 2022-2025

Historic Enterprise Value for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to $3.0 billion.

  • Centessa Pharmaceuticals' Enterprise Value rose 74.42% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 111.15%. This contributed to the annual value of $1.7 billion for FY2024, which is 232.84% up from last year.
  • According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Enterprise Value is $3.0 billion, which was up 99.67% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Enterprise Value peaked at $3.0 billion during Q3 2025, and registered a low of -$117.5 million during Q3 2022.
  • Over the past 3 years, Centessa Pharmaceuticals' median Enterprise Value value was $952.8 million (recorded in 2024), while the average stood at $1.1 billion.
  • Data for Centessa Pharmaceuticals' Enterprise Value shows a peak YoY surged of 3,864.61% (in 2024) over the last 5 years.
  • Over the past 4 years, Centessa Pharmaceuticals' Enterprise Value (Quarterly) stood at -$100.4 million in 2022, then spiked by 618.53% to $520.6 million in 2023, then spiked by 232.84% to $1.7 billion in 2024, then skyrocketed by 74.42% to $3.0 billion in 2025.
  • Its Enterprise Value was $3.0 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.4 billion in Q1 2025.